Paul Edwards Posted April 11, 2016 Share Posted April 11, 2016 “Of the cancer medicines being developed, 91% will be targeted therapies, which is likely to make these medicines more expensive. Pressure on budgets will therefore only increase if something is not done now about cancer drug prices.” Clink on this link to read an article in the online newsletter, MJA InSight, about the increasing costs of cancer drugs. Although the article doesn't offer any solutions to the problem, there are some interesting statistics about the number of cancer drugs (for all cancers, not just prostate cancer) that are likely to be on the market within 5 years. The fact that "Australia represents about 1% of the global pharmaceutical market" explains why Australians have to wait for access to drugs long after they have been approved overseas. We're a very small market in the scheme of things. Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.